Global Tardive Dyskinesia (TD) Therapy Market Growth 2018-2023

October 2018 | 131 pages | ID: G5C50B833CDEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dyskinesia include finger movement, facial grimacing, jaw swinging, repetitive chewing, continuous blinking of the eyes, tongue thrusting, and others. 
Over the next five years, LPI(LP Information) projects that Tardive Dyskinesia (TD) Therapy will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Tardive Dyskinesia (TD) Therapy market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Tardive Dyskinesia (TD) Therapy market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Valbenazine
• Amantadine
• Tetrabenazine
• Clonazepam
• Others

Segmentation by application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Teva Pharma
• Biogen
• Johnson & Johnson
• GlaxoSmithKline
• Neurocrine Biosciences
• Pfizer
• Novartis
• Sanofi
• AstraZeneca
• Bayer AG

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Tardive Dyskinesia (TD) Therapy consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Tardive Dyskinesia (TD) Therapy market by identifying its various subsegments.
• Focuses on the key global Tardive Dyskinesia (TD) Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Tardive Dyskinesia (TD) Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Tardive Dyskinesia (TD) Therapy submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tardive Dyskinesia (TD) Therapy Consumption 2013-2023
  2.1.2 Tardive Dyskinesia (TD) Therapy Consumption CAGR by Region
2.2 Tardive Dyskinesia (TD) Therapy Segment by Type
  2.2.1 Valbenazine
  2.2.2 Amantadine
  2.2.3 Tetrabenazine
  2.2.4 Clonazepam
  2.2.5 Others
2.3 Tardive Dyskinesia (TD) Therapy Consumption by Type
  2.3.1 Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type (2013-2018)
  2.3.2 Global Tardive Dyskinesia (TD) Therapy Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Tardive Dyskinesia (TD) Therapy Sale Price by Type (2013-2018)
2.4 Tardive Dyskinesia (TD) Therapy Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Tardive Dyskinesia (TD) Therapy Consumption by Application
  2.5.1 Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application (2013-2018)
  2.5.2 Global Tardive Dyskinesia (TD) Therapy Value and Market Share by Application (2013-2018)
  2.5.3 Global Tardive Dyskinesia (TD) Therapy Sale Price by Application (2013-2018)

3 GLOBAL TARDIVE DYSKINESIA (TD) THERAPY BY PLAYERS

3.1 Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Players
  3.1.1 Global Tardive Dyskinesia (TD) Therapy Sales by Players (2016-2018)
  3.1.2 Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Players (2016-2018)
3.2 Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Players
  3.2.1 Global Tardive Dyskinesia (TD) Therapy Revenue by Players (2016-2018)
  3.2.2 Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Players (2016-2018)
3.3 Global Tardive Dyskinesia (TD) Therapy Sale Price by Players
3.4 Global Tardive Dyskinesia (TD) Therapy Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Tardive Dyskinesia (TD) Therapy Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Tardive Dyskinesia (TD) Therapy Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 TARDIVE DYSKINESIA (TD) THERAPY BY REGIONS

4.1 Tardive Dyskinesia (TD) Therapy by Regions
  4.1.1 Global Tardive Dyskinesia (TD) Therapy Consumption by Regions
  4.1.2 Global Tardive Dyskinesia (TD) Therapy Value by Regions
4.2 Americas Tardive Dyskinesia (TD) Therapy Consumption Growth
4.3 APAC Tardive Dyskinesia (TD) Therapy Consumption Growth
4.4 Europe Tardive Dyskinesia (TD) Therapy Consumption Growth
4.5 Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption Growth

5 AMERICAS

5.1 Americas Tardive Dyskinesia (TD) Therapy Consumption by Countries
  5.1.1 Americas Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018)
  5.1.2 Americas Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018)
5.2 Americas Tardive Dyskinesia (TD) Therapy Consumption by Type
5.3 Americas Tardive Dyskinesia (TD) Therapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Tardive Dyskinesia (TD) Therapy Consumption by Countries
  6.1.1 APAC Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018)
  6.1.2 APAC Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018)
6.2 APAC Tardive Dyskinesia (TD) Therapy Consumption by Type
6.3 APAC Tardive Dyskinesia (TD) Therapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Tardive Dyskinesia (TD) Therapy by Countries
  7.1.1 Europe Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018)
  7.1.2 Europe Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018)
7.2 Europe Tardive Dyskinesia (TD) Therapy Consumption by Type
7.3 Europe Tardive Dyskinesia (TD) Therapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tardive Dyskinesia (TD) Therapy by Countries
  8.1.1 Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018)
8.2 Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption by Type
8.3 Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Tardive Dyskinesia (TD) Therapy Distributors
10.3 Tardive Dyskinesia (TD) Therapy Customer

11 GLOBAL TARDIVE DYSKINESIA (TD) THERAPY MARKET FORECAST

11.1 Global Tardive Dyskinesia (TD) Therapy Consumption Forecast (2018-2023)
11.2 Global Tardive Dyskinesia (TD) Therapy Forecast by Regions
  11.2.1 Global Tardive Dyskinesia (TD) Therapy Forecast by Regions (2018-2023)
  11.2.2 Global Tardive Dyskinesia (TD) Therapy Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Tardive Dyskinesia (TD) Therapy Forecast by Type
11.8 Global Tardive Dyskinesia (TD) Therapy Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Teva Pharma
  12.1.1 Company Details
  12.1.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.1.3 Teva Pharma Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Teva Pharma News
12.2 Biogen
  12.2.1 Company Details
  12.2.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.2.3 Biogen Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Biogen News
12.3 Johnson & Johnson
  12.3.1 Company Details
  12.3.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.3.3 Johnson & Johnson Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Johnson & Johnson News
12.4 GlaxoSmithKline
  12.4.1 Company Details
  12.4.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 GlaxoSmithKline News
12.5 Neurocrine Biosciences
  12.5.1 Company Details
  12.5.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.5.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Neurocrine Biosciences News
12.6 Pfizer
  12.6.1 Company Details
  12.6.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.6.3 Pfizer Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Pfizer News
12.7 Novartis
  12.7.1 Company Details
  12.7.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.7.3 Novartis Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Novartis News
12.8 Sanofi
  12.8.1 Company Details
  12.8.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.8.3 Sanofi Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Sanofi News
12.9 AstraZeneca
  12.9.1 Company Details
  12.9.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.9.3 AstraZeneca Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 AstraZeneca News
12.10 Bayer AG
  12.10.1 Company Details
  12.10.2 Tardive Dyskinesia (TD) Therapy Product Offered
  12.10.3 Bayer AG Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Bayer AG News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Tardive Dyskinesia (TD) Therapy
Table Product Specifications of Tardive Dyskinesia (TD) Therapy
Figure Tardive Dyskinesia (TD) Therapy Report Years Considered
Figure Market Research Methodology
Figure Global Tardive Dyskinesia (TD) Therapy Consumption Growth Rate 2013-2023 (K Units)
Figure Global Tardive Dyskinesia (TD) Therapy Value Growth Rate 2013-2023 ($ Millions)
Table Tardive Dyskinesia (TD) Therapy Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Valbenazine
Table Major Players of Valbenazine
Figure Product Picture of Amantadine
Table Major Players of Amantadine
Figure Product Picture of Tetrabenazine
Table Major Players of Tetrabenazine
Figure Product Picture of Clonazepam
Table Major Players of Clonazepam
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type (2013-2018)
Figure Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Revenue by Type (2013-2018) ($ million)
Table Global Tardive Dyskinesia (TD) Therapy Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Tardive Dyskinesia (TD) Therapy Value Market Share by Type (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Sale Price by Type (2013-2018)
Figure Tardive Dyskinesia (TD) Therapy Consumed in Hospitals
Figure Global Tardive Dyskinesia (TD) Therapy Market: Hospitals (2013-2018) (K Units)
Figure Global Tardive Dyskinesia (TD) Therapy Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Tardive Dyskinesia (TD) Therapy Consumed in Clinics
Figure Global Tardive Dyskinesia (TD) Therapy Market: Clinics (2013-2018) (K Units)
Figure Global Tardive Dyskinesia (TD) Therapy Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Tardive Dyskinesia (TD) Therapy Consumed in Others
Figure Global Tardive Dyskinesia (TD) Therapy Market: Others (2013-2018) (K Units)
Figure Global Tardive Dyskinesia (TD) Therapy Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application (2013-2018)
Figure Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Value by Application (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Value Market Share by Application (2013-2018)
Figure Global Tardive Dyskinesia (TD) Therapy Value Market Share by Application (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Sale Price by Application (2013-2018)
Table Global Tardive Dyskinesia (TD) Therapy Sales by Players (2016-2018) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Players (2016-2018)
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Players in 2016
Figure Global Tardive Dyskinesia (TD) Therapy Sales Market Share by Players in 2017
Table Global Tardive Dyskinesia (TD) Therapy Revenue by Players (2016-2018) ($ Millions)
Table Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Players (2016-2018)
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Players in 2016
Figure Global Tardive Dyskinesia (TD) Therapy Revenue Market Share by Players in 2017
Table Global Tardive Dyskinesia (TD) Therapy Sale Price by Players (2016-2018)
Figure Global Tardive Dyskinesia (TD) Therapy Sale Price by Players in 2017
Table Global Tardive Dyskinesia (TD) Therapy Manufacturing Base Distribution and Sales Area by Players
Table Players Tardive Dyskinesia (TD) Therapy Products Offered
Table Tardive Dyskinesia (TD) Therapy Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Tardive Dyskinesia (TD) Therapy Consumption by Regions 2013-2018 (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Regions 2013-2018
Figure Global Tardive Dyskinesia (TD) Therapy Consumption Market Share by Regions 2013-2018
Table Global Tardive Dyskinesia (TD) Therapy Value by Regions 2013-2018 ($ Millions)
Table Global Tardive Dyskinesia (TD) Therapy Value Market Share by Regions 2013-2018
Figure Global Tardive Dyskinesia (TD) Therapy Value Market Share by Regions 2013-2018
Figure Americas Tardive Dyskinesia (TD) Therapy Consumption 2013-2018 (K Units)
Figure Americas Tardive Dyskinesia (TD) Therapy Value 2013-2018 ($ Millions)
Figure APAC Tardive Dyskinesia (TD) Therapy Consumption 2013-2018 (K Units)
Figure APAC Tardive Dyskinesia (TD) Therapy Value 2013-2018 ($ Millions)
Figure Europe Tardive Dyskinesia (TD) Therapy Consumption 2013-2018 (K Units)
Figure Europe Tardive Dyskinesia (TD) Therapy Value 2013-2018 ($ Millions)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption 2013-2018 (K Units)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Value 2013-2018 ($ Millions)
Table Americas Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018) (K Units)
Table Americas Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries (2013-2018)
Figure Americas Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries in 2017
Table Americas Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018) ($ Millions)
Table Americas Tardive Dyskinesia (TD) Therapy Value Market Share by Countries (2013-2018)
Figure Americas Tardive Dyskinesia (TD) Therapy Value Market Share by Countries in 2017
Table Americas Tardive Dyskinesia (TD) Therapy Consumption by Type (2013-2018) (K Units)
Table Americas Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type (2013-2018)
Figure Americas Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type in 2017
Table Americas Tardive Dyskinesia (TD) Therapy Consumption by Application (2013-2018) (K Units)
Table Americas Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application (2013-2018)
Figure Americas Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application in 2017
Figure United States Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure United States Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Canada Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Canada Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Mexico Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Mexico Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Table APAC Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018) (K Units)
Table APAC Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries (2013-2018)
Figure APAC Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries in 2017
Table APAC Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018) ($ Millions)
Table APAC Tardive Dyskinesia (TD) Therapy Value Market Share by Countries (2013-2018)
Figure APAC Tardive Dyskinesia (TD) Therapy Value Market Share by Countries in 2017
Table APAC Tardive Dyskinesia (TD) Therapy Consumption by Type (2013-2018) (K Units)
Table APAC Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type (2013-2018)
Figure APAC Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type in 2017
Table APAC Tardive Dyskinesia (TD) Therapy Consumption by Application (2013-2018) (K Units)
Table APAC Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application (2013-2018)
Figure APAC Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application in 2017
Figure China Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure China Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Japan Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Japan Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Korea Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Korea Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure India Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure India Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Australia Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Australia Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Table Europe Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries (2013-2018)
Figure Europe Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries in 2017
Table Europe Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018) ($ Millions)
Table Europe Tardive Dyskinesia (TD) Therapy Value Market Share by Countries (2013-2018)
Figure Europe Tardive Dyskinesia (TD) Therapy Value Market Share by Countries in 2017
Table Europe Tardive Dyskinesia (TD) Therapy Consumption by Type (2013-2018) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type (2013-2018)
Figure Europe Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type in 2017
Table Europe Tardive Dyskinesia (TD) Therapy Consumption by Application (2013-2018) (K Units)
Table Europe Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application (2013-2018)
Figure Europe Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application in 2017
Figure Germany Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Germany Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure France Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure France Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure UK Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure UK Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Italy Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Italy Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Russia Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Russia Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Spain Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Spain Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption Market Share by Countries in 2017
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Value Market Share by Countries in 2017
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption Market Share by Type in 2017
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption Market Share by Application in 2017
Figure Egypt Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Egypt Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure South Africa Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure South Africa Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Israel Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Israel Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure Turkey Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure Turkey Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Value Growth 2013-2018 ($ Millions)
Table Tardive Dyskinesia (TD) Therapy Distributors List
Table Tardive Dyskinesia (TD) Therapy Customer List
Figure Global Tardive Dyskinesia (TD) Therapy Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Tardive Dyskinesia (TD) Therapy Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Market Forecast by Regions
Table Global Tardive Dyskinesia (TD) Therapy Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Tardive Dyskinesia (TD) Therapy Value Market Share Forecast by Regions
Figure Americas Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Americas Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure APAC Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure APAC Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Europe Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Europe Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Middle East & Africa Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure United States Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure United States Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Canada Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Canada Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Mexico Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Mexico Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Brazil Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Brazil Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure China Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure China Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Japan Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Japan Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Korea Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Korea Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Southeast Asia Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Southeast Asia Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure India Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure India Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Australia Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Australia Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Germany Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Germany Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure France Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure France Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure UK Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure UK Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Italy Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Italy Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Russia Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Russia Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Spain Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Spain Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Egypt Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Egypt Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure South Africa Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure South Africa Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Israel Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Israel Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure Turkey Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure Turkey Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Consumption 2018-2023 (K Units)
Figure GCC Countries Tardive Dyskinesia (TD) Therapy Value 2018-2023 ($ Millions)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Forecast by Type (2018-2023) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Market Share Forecast by Type (2018-2023)
Table Global Tardive Dyskinesia (TD) Therapy Value Forecast by Type (2018-2023) ($ Millions)
Table Global Tardive Dyskinesia (TD) Therapy Value Market Share Forecast by Type (2018-2023)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Forecast by Application (2018-2023) (K Units)
Table Global Tardive Dyskinesia (TD) Therapy Consumption Market Share Forecast by Application (2018-2023)
Table Global Tardive Dyskinesia (TD) Therapy Value Forecast by Application (2018-2023) ($ Millions)
Table Global Tardive Dyskinesia (TD) Therapy Value Market Share Forecast by Application (2018-2023)
Table Teva Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharma Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Pharma Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biogen Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table Neurocrine Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Neurocrine Biosciences Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Neurocrine Biosciences Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Tardive Dyskinesia (TD) Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer AG Tardive Dyskinesia (TD) Therapy Market Share (2016-2018)